Structural Formula For Linezolid (Linezolid Injection 1)
Linezolid Injection, Solution
Product Images NDC 0143-9534
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Linezolid (NDC 0143-9534). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Linezolid Injection 2)
Final-inner-bag (Linezolid Injection 3)
Linezolid Injection is a single-dose solution contained in a flexible container, used under prescription with the dosage indicated in the prescription information. The solution contains 2 mg/mL of Linezolid, alongside dextrose, sodium citrate, citric acid, and water for injection. The PH balance is adjusted to 4.8 with sodium hydroxide and hydrochloric acid. During storage, Linezolid solution for injection should not be frozen and should be kept at temperatures ranging from 20 to 25 degrees Celsius. The solution should not be used in series connections or with supplementary medication. Additionally, check container leaks by squeezing the container, and when leaks are detected, the container should be discarded to avoid destroying its sterility. The unused portion of the solution should also be discarded for safety purposes. The solution is manufactured by Hikma farmaceutica in Portugal and distributed in the US by Hikma Pharmaceuticals USA Inc. The text also includes the product's NDC number and Rx-only label.*
Final Overwrap (Linezolid Injection 4)
This is a medication called Linezolid Injection, for intravenous administration in a single-dose flexible container. Each mL contains 2 mg of linezolid, along with other ingredients like dextrose and citric acid. Its usual dosage is indicated in the prescribing information. It is sensitive to light so should be stored in the overwrap prior to use. It should be stored at 20° to 25°C (68° to 77°F) and not be frozen. It is manufactured by HIKMA FARMAGEUTICA (PORTUGAL), S and distributed by Hikma Pharmaceuticals USA Inc. It comes with instructions to check for leaks and discard if leaks are found as sterility may be impaired. The text also includes a few regulatory numbers and markings that are specific to this batch of the medication.*
Representative Serialization Image (Linezolid Injection 5)
This text appears to be a product label or identifier. It includes a Global Trade Item Number (GTIN) and a serial number (SN) which can be used to track the item. Additionally, there is a lot number (LOT) and an expiration date (EXP). However, without additional context it is not possible to determine what type of product this label applies to.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
